نتائج البحث - "Ee, Vokes"

المؤلفون: Ross HJ; Rush University Cancer Center, Chicago, Illinois., Kozono D; Dana-Farber/Partners CancerCare, Boston, Massachusetts., Wang XF; Alliance Statistics and Data Management Center and Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Urbanic JJ; Radiation Medicine and Applied Sciences, University of California, San Diego., Williams TM; Radiation Oncology, City of Hope, Duarte, California., Nelson GD; Department of Quantitative Health Sciences, Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Carbone DP; Internal Medicine, Medical Oncology, The Ohio State University, Columbus., Chung D; Internal Medicine, Medical Oncology, The Ohio State University, Columbus., Robb R; Radiation Oncology, University of North Carolina, Chapel Hill., Byun WY; Internal Medicine, Medical Oncology, The Ohio State University, Columbus., Talabere T; Internal Medicine, Medical Oncology, The Ohio State University, Columbus., DuFrane C; Alliance Foundation Trials, Boston, Massachusetts., Bara I; Genentech, Inc, South San Francisco, California., Schulze K; Genentech, Inc, South San Francisco, California., Brockman M; Genentech, Inc, South San Francisco, California., Gao J; Alliance Statistics and Data Management Center and Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Vokes EE; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Illinois., Stinchcombe TE; Duke Cancer Institute, Duke University, Durham, North Carolina.

المصدر: JAMA oncology [JAMA Oncol] 2024 Jul 25. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

5

دورية أكاديمية

Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.

المؤلفون: Rosenberg AJ; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Agrawal N; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Illinois., Juloori A; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois., Cursio J; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Gooi Z; Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Illinois., Blair E; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Illinois., Chin J; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois., Ginat D; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Radiology, University of Chicago, Chicago, Illinois., Pasternak-Wise O; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Radiology, University of Chicago, Chicago, Illinois., Hasina R; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Illinois., Starus A; Sysmex-Inostics Inc, Baltimore, Maryland., Jones FS; Sysmex-Inostics Inc, Baltimore, Maryland., Izumchenko E; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., MacCracken E; Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Illinois., Wolk R; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Pathology, University of Chicago, Chicago, Illinois., Cipriani N; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Pathology, University of Chicago, Chicago, Illinois., Lingen MW; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Pathology, University of Chicago, Chicago, Illinois., Pearson AT; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Seiwert TY; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland., Haraf DJ; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois., Vokes EE; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.

المصدر: JAMA oncology [JAMA Oncol] 2024 Jul 01; Vol. 10 (7), pp. 923-931.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

6

دورية أكاديمية

Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites.

المؤلفون: Hou Y; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, ShaanXi, China.; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Yang K; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Wang L; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Wang J; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Huang X; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Piffkó A; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Luo SZ; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Yu X; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Rao E; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Martinez C; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Bugno J; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois.; The Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois., Mack M; Department of Nephrology, University Hospital Regensburg, Regensburg, Germany., Vokes EE; Department of Medicine, University of Chicago, Chicago, Illinois., Pitroda SP; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Chmura SJ; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois., Weichselbaum RR; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois., Liang HL; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.; Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1945-1958.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen*/metabolism , Myeloid-Derived Suppressor Cells*/immunology , Myeloid-Derived Suppressor Cells*/metabolism, Animals ; Mice ; Humans ; Neoplasm Metastasis ; Cell Line, Tumor ; Female ; Disease Models, Animal ; Chemokine CXCL10/metabolism

7

دورية أكاديمية

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.

المؤلفون: Vokes EE; University of Chicago Medicine and Biological Sciences, Chicago, Illinois., Mornex F; Centre Hospitalier Universitaire, Lyon, France., Sezer A; Baskent University Adana Application and Research Center, Turkey., Cheng Y; Jilin Cancer Hospital, People's Republic of China., Fang J; Beijing Cancer Hospital, People's Republic of China., Baz DV; Hospital Universitario Virgen Macarena, Spain., Cil T; Adana City Hospital, Health and Science University, Adana, Turkey., Adjei AA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Barlesi F; Aix-Marseille University, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Cancer Research Center of Marseille (CRCM), Assistance Publique Hopitaux de Marseille (APHM), Marseille, France; Paris-Saclay University, Gustave Roussy Cancer Campus, Villejuif, France., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain., Garon EB; David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California., Audhuy F; Merck Serono S.A.S. (an affiliate of Merck KGaA, Darmstadt, Germany), Lyon, France., Ito R; Merck Biopharma Co., Ltd., (an affiliate of Merck KGaA, Darmstadt, Germany), Tokyo, Japan., Sato M; Merck Biopharma Co., Ltd., (an affiliate of Merck KGaA, Darmstadt, Germany), Tokyo, Japan., Eggleton SP; Merck Sereno Ltd. Feltham (an affiliate of Merck KGaA, Darmstadt, Germany), Feltham, United Kingdom., Martin CM; Alexander Fleming Institute, Buenos Aires, Argentina., Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany., Robinson CG; Washington University in St. Louis School of Medicine, St. Louis, Missouri., Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Ciberonc, Madrid, Spain; Complutense University, Madrid, Spain. Electronic address: lpazaresr@seom.org.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Feb; Vol. 19 (2), pp. 285-296. Date of Electronic Publication: 2023 Oct 04.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy, Humans ; Antibodies, Monoclonal/therapeutic use ; Chemoradiotherapy ; Immunologic Factors/therapeutic use ; Neoplasm Staging

8

دورية أكاديمية

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.

المؤلفون: Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee JS; Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China., Cicin I; Department of Medical Oncology, Trakya University, Edirne, Turkey., Dols MC; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga, Málaga, Spain., Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Cuppens K; Department of Pulmonology and Thoracic Oncology, Jessa Hospital, Hasselt, Belgium., Veillon R; Centre Hospitalier Universitaire (CHU) Bordeaux, Service des Maladies Respiratoires, Bordeaux, France., Nadal E; Catalan Institute of Oncology and Clinical Research in Solid Tumors Group, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet, Barcelona, Spain., Dias JM; Barretos Cancer Hospital, Barretos, Brazil., Martin C; Instituto Alexander Fleming, Buenos Aires, Argentina., Reck M; Airway Research Center North, German Center for Lung Research, LungenClinic, Grosshansdorf, Germany., Garon EB; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California., Felip E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Unit, Universidad Complutense and CiberOnc, Madrid, Spain., Mornex F; CHU Lyon, Université Claude-Bernard Lyon 1, Lyon, France., Vokes EE; University of Chicago Medicine and Biological Sciences, Chicago, Illinois., Adjei AA; Cleveland Clinic, Cleveland, Ohio., Robinson C; Washington University School of Medicine, St. Louis, Missouri., Sato M; Merck Biopharma Co., Ltd., Tokyo, Japan, an affiliate of Merck KGaA, Darmstadt, Germany., Vugmeyster Y; EMD Serono, Billerica, Massachusetts., Machl A; EMD Serono, Billerica, Massachusetts., Audhuy F; the Healthcare Business of Merck KGaA, Darmstadt, Germany., Chaudhary S; EMD Serono, Billerica, Massachusetts., Barlesi F; Aix Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille, France; Université Paris-Saclay, Gustave Roussy, Villejuif, France. Electronic address: fabrice.barlesi@gustaveroussy.fr.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Dec; Vol. 18 (12), pp. 1731-1742. Date of Electronic Publication: 2023 Aug 18.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms* , Carcinoma, Non-Small-Cell Lung*, Humans ; B7-H1 Antigen/metabolism ; Immunologic Factors/therapeutic use

9

دورية أكاديمية

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.

المؤلفون: Bestvina CM; Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL., Garassino MC; Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL., Neal JW; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Wakelee HA; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Diehn M; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Vokes EE; Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Sep 01; Vol. 41 (25), pp. 4093-4096. Date of Electronic Publication: 2023 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Carcinoma, Non-Small-Cell Lung*/pathology, Humans ; Biomarkers, Tumor/genetics

View record in Lippincott, Williams & Wilkins

10

دورية أكاديمية

A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.

المؤلفون: Rosenberg AJ; Department of Medicine, University of Chicago, Chicago, USA; University of Chicago Comprehensive Cancer Center, Chicago, USA. Electronic address: Arirosenberg@medicine.bsd.uchicago.edu., Liao CY; Department of Medicine, University of Chicago, Chicago, USA; University of Chicago Comprehensive Cancer Center, Chicago, USA., Karrison T; Department of Public Health Sciences, University of Chicago, Chicago, USA., de Souza JA; HCA Healthcare, Nashville, USA., Worden FP; University of Michigan Comprehensive Cancer Center, Ann Arbor, USA., Libao B; Department of Medicine, University of Chicago, Chicago, USA., Krzyzanowska MK; Princess Margaret Cancer Centre, Toronto, Canada., Hayes DN; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, USA., Winquist E; Department of Oncology, University of Western Ontario and London Health Sciences Centre, London, Canada., Saloura V; National Cancer Institute, Bethesda, USA., Prescott K; University of Illinois Chicago, Chicago, USA., Villaflor VM; City of Hope Comprehensive Cancer Center, Duarte, USA., Seiwert TY; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA., Schechter RB; Department of Medicine, University of Chicago, Chicago, USA., Stadler WM; Department of Medicine, University of Chicago, Chicago, USA; University of Chicago Comprehensive Cancer Center, Chicago, USA., Cohen EEW; Moores Cancer Center at UC San Diego, La Jolla, USA., Vokes EE; Department of Medicine, University of Chicago, Chicago, USA; University of Chicago Comprehensive Cancer Center, Chicago, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Aug; Vol. 34 (8), pp. 714-722. Date of Electronic Publication: 2023 May 13.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Thyroid Neoplasms*/pathology , Adenocarcinoma*/drug therapy, Humans ; Infant ; Iodine Radioisotopes/adverse effects ; Lenalidomide/adverse effects ; Vascular Endothelial Growth Factor A ; Receptors, Vascular Endothelial Growth Factor

تنقيح النتائج